BeOne Medicines Ltd.SSE: 688235

Semi-annual Report in 2024

Aug 30, 2024 · Issued by BeOne Medicines Ltd. via Shanghai Stock Exchange

Filed with SSE · Aug 30, 2024

On 6ix: 6ix.com/news/semi-annual-report-in-2024-93

Semi-annual Report in 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

BeOne Medicines Ltd. on 6ix

Earlier from BeOne Medicines

Announcement on Convening Semi-annual Performance Briefing 2024Aug 22, 2024
Announcement on Key Financial Data for the First Half Year of 2024Aug 8, 2024
Announcement on Change of Senior ExecutiveJul 19, 2024
Announcement on Key Financial Data of 1st Quarter of 2024May 9, 2024
Notice on Convening 2024 Annual General MeetingApr 29, 2024

Later from BeOne Medicines

Announcement on the Equity Registration Date for the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2024Sep 21, 2024
Announcement on the Appointment of Independent Non-executive Directors and Members of Audit Committee of the Board of DirectorsSep 27, 2024
Announcement on the Death of the Independent Non-executive DirectorOct 29, 2024
Announcement on Convening the Q3 2024 Performance BriefingNov 6, 2024
Announcement on Using Partial Extra Raised Funds to Supplement Current Capital PermanentlyNov 13, 2024

All BeOne Medicines news releases

Follow BeOne Medicines into a list and get an email when it puts out news.

Follow BeOne Medicines